No headlines found.
No press releases found.
No news found.
iShares Health Innovation Active ETF will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. Companies in the health sciences group of industries include health care providers as well as businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment or services or that provide support services to these companies. These companies also include those that own or operate health facilities and hospitals or provide related administrative, management or financial support. Other companies in the health sciences group of industries in which the Fund may invest include clinical testing laboratories diagnostics hospital, laboratory or physician ancillary products and support services rehabilitation services employer health insurance management services and vendors of goods and services specifically to companies engaged in the health sciences. The Fund will concentrate its investments in the health sciences group of industries.
iShares Health Innovation Active ETF trades on the ARCA stock market under the symbol BMED.
As of April 17, 2026, BMED stock price climbed to $29.51 with 419 million shares trading.
BMED has a market cap of $10.62 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BMED traded as high as $32.19 and as low as $20.57.
BMED has underperformed the market in the last year with a price return of +29.2% while the SPY ETF gained +36.5%. BMED has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.3% and +2.1%, respectively, while the SPY returned +2.9% and +8.3%, respectively.
BMED support price is $28.68 and resistance is $29.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMED shares will trade within this expected range on the day.
